Related Experiment Video

Updated: Mar 1, 2026

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

8.5K

Dyrk1B overexpression is associated with breast cancer growth and a poor prognosis

Yingying Chen1, Shuo Wang2, Zhixian He3

  • 1Department of Immunology, Medical College, Nantong University, Nantong 226001, Jiangsu Province, People's Republic of China; Department of Oncology, Affiliated Hospital of Nantong University, Nantong 226001, China.

Human Pathology
|May 31, 2017
PubMed

Insights

Dual-specificity tyrosine phosphorylation-regulated kinase 1B (Dyrk1B) is overexpressed in breast cancer, driving tumor progression and poor prognosis. Inhibiting Dyrk1B halts cancer cell growth, suggesting it as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Dyrk1B (minibrain-related kinase) is a serine/threonine kinase regulating tumor progression and cell proliferation.
  • Its specific role in breast cancer development requires further investigation.

Purpose of the Study:

  • To investigate the role of Dyrk1B in breast cancer development and progression.
  • To explore Dyrk1B as a potential therapeutic target for breast cancer.

Main Methods:

  • Western blot and immunohistochemistry were used to detect Dyrk1B expression in breast cancer tissues and cells.
  • Small interfering RNA (siRNA) was employed to knock out DYRK1B gene expression.
  • FoxO1 phosphorylation and subcellular localization were analyzed.

Main Results:

  • Dyrk1B was significantly overexpressed in breast cancer tissues and cells compared to normal tissues.
  • High Dyrk1B expression correlated with adverse clinicopathologic factors (tumor size, grade, ER status, Ki-67) and predicted poor prognosis.
  • siRNA-mediated DYRK1B knockout inhibited breast cancer cell growth.
  • Dyrk1B phosphorylates FoxO1, leading to its cytoplasmic translocation, potentially mediating cancer cell survival.

Conclusions:

  • Dyrk1B plays a critical role in breast cancer progression.
  • Dyrk1B represents a promising therapeutic target for breast cancer treatment.
Keywords:
Breast cancerCell proliferationDyrk1BFoxO1Prognosis

More Related Videos

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.4K
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.7K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.8K